US6316642B1
(en)
*
|
1997-03-17 |
2001-11-13 |
Wisconsin Alumni Research Foundation |
26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
|
US5945410A
(en)
*
|
1997-03-17 |
1999-08-31 |
Wisconsin Alumni Research Foundation |
2-alkyl-19-nor-vitamin D compounds
|
US6392071B1
(en)
*
|
1997-03-17 |
2002-05-21 |
Wisconsin Alumni: Research Foundation |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
|
MA26481A1
(fr)
*
|
1997-04-21 |
2004-12-20 |
Hoffmann La Roche |
Derives d'arylsecocholadiene
|
US5936105A
(en)
*
|
1997-06-13 |
1999-08-10 |
Tetrionics, Inc. |
14-EPI-19-nor-vitamin D compounds and methods
|
US20030188756A1
(en)
*
|
2002-08-19 |
2003-10-09 |
Cantorna Margherita T |
Treatment of inflammatory bowel disease with vitamin d compounds
|
US6359012B1
(en)
*
|
1999-12-22 |
2002-03-19 |
Bone Care International, Inc. |
Method for making 24(S)-hydroxyvitamin D2
|
IL152942A
(en)
*
|
2000-05-31 |
2007-09-20 |
Wisconsin Alumni Res Found |
Compounds 2 - Ethyl and 2 - Ethylaidine - 19 - Nur - Vitamin D and pharmaceutical preparations containing them
|
AU7888801A
(en)
*
|
2000-07-14 |
2002-01-30 |
Wisconsin Alumni Res Found |
Use of 2-methylene-19-nor-20(s)-1alpha,25-dihydroxyvitamin D<sub>3</sub> to increase bone strength
|
ATE273709T1
(de)
|
2000-09-08 |
2004-09-15 |
Wisconsin Alumni Res Found |
1alpha-hydroxy-2-methylene-19-nor- homopregnacalciferol und seine therapeutische verwendungen
|
EE200300448A
(et)
*
|
2001-03-15 |
2004-02-16 |
Basf Aktiengesellschaft |
5-fenüülpürimidiinid, meetodid ja vaheühendid nende valmistamiseks ning nende kasutamine patogeensete seente tõrjeks
|
US6683219B2
(en)
*
|
2001-07-30 |
2004-01-27 |
Wisconsin Alumni Research Foundation |
Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
|
US6835723B2
(en)
*
|
2001-12-13 |
2004-12-28 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
|
US6627622B2
(en)
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
ATE411283T1
(de)
*
|
2001-12-13 |
2008-10-15 |
Wisconsin Alumni Res Found |
(20s)-1 alpha-hydroxy-2-methylen-19-nor- bishomopregnacalciferol und ihre verwendungen
|
US6566352B1
(en)
|
2002-02-18 |
2003-05-20 |
Wisconsin Alumni Research Foudation |
1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
|
US6964784B2
(en)
*
|
2002-03-07 |
2005-11-15 |
Optigenex, Inc. |
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
|
US20030195175A1
(en)
*
|
2002-03-25 |
2003-10-16 |
Deluca Hector F. |
Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
|
JP3957303B2
(ja)
*
|
2002-03-29 |
2007-08-15 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
1α−ヒドロキシ−2−メチレン−19−ノル−ホモプレグナカルシフェロールの合成法
|
US6846811B2
(en)
*
|
2002-04-22 |
2005-01-25 |
Wisconsin Alumni Research Foundation |
(20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
|
US7259143B2
(en)
*
|
2002-09-05 |
2007-08-21 |
Wisconsin Alumni Research Foundation |
Method of extending the dose range of vitamin D compounds
|
US20080249068A1
(en)
*
|
2002-09-05 |
2008-10-09 |
Deluca Hector F |
Method of Extending the Dose Range of Vitamin D Compounds
|
WO2004076468A1
(ja)
|
2003-02-25 |
2004-09-10 |
Kobe Tennenbutsu Kagaku Kabushiki Kaisha |
ビタミンd誘導体を合成するための新規な中間体
|
ATE556999T1
(de)
*
|
2003-04-10 |
2012-05-15 |
Wisconsin Alumni Res Found |
2-propyliden-19-nor-vitamin d verbindungen
|
US6894037B2
(en)
*
|
2003-07-03 |
2005-05-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
|
MXPA06000060A
(es)
*
|
2003-07-03 |
2006-04-07 |
Wisconsin Alumni Res Found |
2-metilen-19-nor-20(s)-25-metil-1alfa-hidroxicalciferol y sus usos.
|
US20050009792A1
(en)
*
|
2003-07-08 |
2005-01-13 |
Deluca Hector F. |
(20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
|
US20050209203A1
(en)
*
|
2003-07-30 |
2005-09-22 |
Jin Tian |
Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
|
NZ545862A
(en)
*
|
2003-08-20 |
2010-01-29 |
Wisconsin Alumni Res Found |
2-Methylene-19-nor-vitamin D2 compounds
|
WO2005027916A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
|
AU2004273672A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
|
WO2005027929A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen
|
WO2005027927A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for enhancement of peak bone mass in adolescence
|
WO2005027928A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
|
WO2005027922A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
|
BRPI0414564A
(pt)
*
|
2003-09-19 |
2006-11-07 |
Pfizer Prod Inc |
derivados de 2-alcilideno-19-nor-vitamina d para tratamento de fraqueza, lesão muscular ou sarcopenia
|
WO2005027920A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of rickets or vitamin d deficiency
|
WO2005027919A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
|
WO2005027925A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior
|
WO2005027931A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
|
WO2005027930A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
|
WO2005027918A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
|
CN100413507C
(zh)
*
|
2003-09-19 |
2008-08-27 |
威斯康星州男校友研究基金会 |
治疗骨质稀少或雄性骨质疏松的2-亚烷基-19-去甲-维生素d衍生物
|
BRPI0414518A
(pt)
*
|
2003-09-19 |
2006-11-07 |
Pfizer Prod Inc |
composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
AU2004273658A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Wisconsin Alumni Research Foundation (Warf) |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
|
WO2005027926A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bone morphogenetic protein
|
US7214670B2
(en)
*
|
2003-09-24 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
|
US7704980B2
(en)
*
|
2003-10-08 |
2010-04-27 |
Wisconsin Alumni Research Foundation |
Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
|
JP2007512376A
(ja)
*
|
2003-11-25 |
2007-05-17 |
ウイスコンシン アラムニ リサーチ ファンデーション |
肥満症の予防及び治療用ビタミンd類似体
|
JP2007512371A
(ja)
*
|
2003-11-25 |
2007-05-17 |
デルタノイド ファーマシューティカルズ,インコーポレイティド |
ビタミン化合物を用いる体脂肪の減少方法
|
WO2005079464A2
(en)
*
|
2004-02-17 |
2005-09-01 |
Wisconsin Alumni Research Foundation |
Vitamin d receptor antagonists and their use in treating asthma
|
US7214671B2
(en)
|
2004-02-19 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
|
US7713951B2
(en)
*
|
2004-04-09 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-alkylidene-18,19-dinor-vitamin D compounds
|
WO2006051106A1
(en)
|
2004-11-12 |
2006-05-18 |
Bioxell Spa |
Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
|
AU2005309818A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20R)-1-alpha-hydroxy-bishomopregnacalciferol
|
CA2588060A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol
|
MX2007006094A
(es)
*
|
2004-11-22 |
2007-07-11 |
Wisconsin Alumni Res Found |
2-metilen-19,21-dinor-1a-hidroxi-bishomopregnacalciferol.
|
EP1817278B1
(en)
*
|
2004-11-22 |
2010-06-30 |
Wisconsin Alumni Research Foundation |
2-methylene-18,19-dinor-1alfa-hydroxy-homopregnacalciferol and its uses
|
MX2007006545A
(es)
*
|
2004-11-22 |
2007-09-21 |
Wisconsin Alumni Res Found |
2a-metil-19-nor-1a-hidroxi-homopregnacalciferol y sus usos.
|
ATE467614T1
(de)
*
|
2004-11-22 |
2010-05-15 |
Wisconsin Alumni Res Found |
2-methylen-19,26,27-trinor-(20s)-1-alpha- hydroxyvitamin d3 and dessen verwendungen
|
DE602005021538D1
(de)
*
|
2004-11-22 |
2010-07-08 |
Wisconsin Alumni Res Found |
17,20(z)-dehydro-vitamin-d-analoge und deren verwendungen
|
US7563783B2
(en)
*
|
2005-02-11 |
2009-07-21 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2
|
ATE554774T1
(de)
*
|
2005-02-11 |
2012-05-15 |
Wisconsin Alumni Res Found |
2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2
|
CA2603328A1
(en)
*
|
2005-03-29 |
2006-10-05 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(23s)-25-dehydro-1.alpha.-hydroxyvitamin d3-26,23-lactone and 2-methylene-19-nor-(23r)-25-dehydro-1.alpha.-hydroxyvitamin d3-26,23-lactone
|
NZ563758A
(en)
*
|
2005-05-03 |
2010-04-30 |
Wisconsin Alumni Res Found |
19,26,27-Trinor-1alpha,25-dihydroxyvitamin D3 compounds
|
NZ567015A
(en)
*
|
2005-08-30 |
2010-12-24 |
Wisconsin Alumni Res Found |
Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
|
CA2623481A1
(en)
*
|
2005-09-22 |
2007-04-05 |
Wisconsin Alumni Research Foundation |
19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
|
US7803789B2
(en)
*
|
2006-02-02 |
2010-09-28 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—RAK, methods and uses thereof
|
US7528122B2
(en)
*
|
2006-02-02 |
2009-05-05 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—NEL, methods and uses thereof
|
US8058265B2
(en)
*
|
2006-04-05 |
2011-11-15 |
Wisconsin Alumni Research Foundation |
1a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof
|
US20090281340A1
(en)
*
|
2006-04-05 |
2009-11-12 |
Deluca Hector F |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof
|
EP2001842B1
(en)
*
|
2006-04-06 |
2012-06-06 |
Wisconsin Alumni Research Foundation |
2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
|
US8193169B2
(en)
*
|
2006-04-06 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
|
MX2008012913A
(es)
*
|
2006-04-06 |
2009-03-06 |
Wisconsin Alumni Res Found |
2-metilen-1a,25-dihidroxi-18,19,21-trinorvitamina d3 y sus usos.
|
JP2009532460A
(ja)
*
|
2006-04-06 |
2009-09-10 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−置換−1α,25−ジヒドロキシ−19,26,27−トリノルビタミンD類縁体およびその使用
|
US7538098B2
(en)
*
|
2006-04-06 |
2009-05-26 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring
|
CA2648324A1
(en)
|
2006-04-06 |
2007-10-18 |
Wisconsin Alumni Research Foundation |
2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof
|
AU2007298651A1
(en)
*
|
2006-04-06 |
2008-03-27 |
Wisconsin Alumni Research Foundation |
2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
|
EP2004597B1
(en)
*
|
2006-04-10 |
2011-01-26 |
Wisconsin Alumni Research Foundation |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain
|
MX2009003241A
(es)
*
|
2006-09-28 |
2009-05-05 |
Wisconsin Alumni Res Found |
Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d.
|
WO2008039751A2
(en)
*
|
2006-09-28 |
2008-04-03 |
Wisconsin Alumni Research Foundation |
2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
|
WO2008089093A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Quatrx Pharmaceuticals Company |
Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
|
AU2008345086B2
(en)
*
|
2007-12-28 |
2014-02-13 |
Wisconsin Alumni Research Foundation |
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs
|
CA2710966C
(en)
*
|
2007-12-28 |
2015-10-13 |
Wisconsin Alumni Research Foundation |
(20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
|
CA2710970A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Wisconsin Alumni Research Foundation |
2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
|
JP2011508743A
(ja)
*
|
2007-12-28 |
2011-03-17 |
ウィスコンシン アラムナイ リサーチ ファンデーション |
(20s)−23,23−ジフルオロ−2−メチレン−19−ノル−ビスホモプレグナカルシフェロール−ビタミンd類縁体
|
JP2011507965A
(ja)
*
|
2007-12-28 |
2011-03-10 |
ウィスコンシン アラムナイ リサーチ ファンデーション |
2−メチレン−(20s,25s)−19,26−ジノル−ビタミンd類縁体
|
MX2010007956A
(es)
*
|
2008-01-22 |
2010-09-14 |
Wisconsin Alumni Reasearch Fou |
Analogos de 13,13-dimetil-des-c,d de compuestos de 1a,25-dihidroxi-19-nor-vitamina d3 y formas de dosificacion de composicion topica y metodos de tratamiento de condiciones de la piel.
|
US7879829B2
(en)
*
|
2008-07-10 |
2011-02-01 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 1,2-dihydrofuran ring
|
US8222236B2
(en)
*
|
2008-07-10 |
2012-07-17 |
Wisconsin Alumni Research Foundation |
2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
|
US8399439B2
(en)
*
|
2008-07-10 |
2013-03-19 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
|
US8193170B2
(en)
|
2008-07-10 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
|
US7893043B2
(en)
|
2008-07-10 |
2011-02-22 |
Wisconsin Alumni Research Foundation |
2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
|
US7713953B2
(en)
*
|
2008-07-10 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
US7648974B1
(en)
*
|
2008-07-10 |
2010-01-19 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 3,2-dihydrofuran ring
|
US7888339B2
(en)
|
2008-07-10 |
2011-02-15 |
Wisconsin Alumni Research Foundation |
2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
|
EP2419403B1
(en)
*
|
2009-04-17 |
2016-09-07 |
Vidasym, Inc. |
Vitamin d receptor agonists and uses thereof
|
AU2010281391B2
(en)
|
2009-08-03 |
2015-05-07 |
Wisconsin Alumni Research Foundation |
Method of preventing renal disease and treating symptoms thereof
|
WO2011041596A2
(en)
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring
|
CA2776464C
(en)
|
2009-10-02 |
2017-10-24 |
Wisconsin Alumni Research Foundation |
1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
|
WO2011041599A2
(en)
*
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
6-methylvitamin d3 analogs and their uses
|
WO2011041579A2
(en)
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
(20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS
|
EP2490695B1
(en)
|
2009-10-21 |
2013-11-20 |
Wisconsin Alumni Research Foundation |
Method of preventing type 1 diabetes
|
US8664206B2
(en)
|
2010-03-23 |
2014-03-04 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
|
CA2793727C
(en)
*
|
2010-03-23 |
2017-01-03 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin d3
|
ES2545403T3
(es)
*
|
2010-03-23 |
2015-09-10 |
Wisconsin Alumni Research Foundation |
(20S)-2-metilen-19-nor-22-dimetil-1alfa,25-dihidroxivitamina D3 y (20R)-2-metilen-19-nor-22-dimetil-1alfa,25-hidroxivitamina D3
|
AU2011308911B2
(en)
|
2010-09-30 |
2014-10-02 |
Wisconsin Alumni Research Foundation |
(20R,25S)-2-methylene-19,26-dinor-1alpha, 25-dihydroxyvitamin D3 in crystalline form
|
US8754067B2
(en)
|
2010-11-12 |
2014-06-17 |
Wisconsin Alumni Research Foundation |
22-haloacetoxy-homopregnacalciferol analogs and their uses
|
WO2012151058A1
(en)
|
2011-05-03 |
2012-11-08 |
Wisconsin Alumni Research Foundation |
(20s)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin d3 analogs and their uses
|
US8987235B2
(en)
|
2011-05-17 |
2015-03-24 |
Wisconsin Alumni Research Foundation |
N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
|
CA2837882C
(en)
|
2011-06-03 |
2019-03-26 |
Wisconsin Alumni Research Foundation |
(22e)-2-methylene-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamin d3 derivatives
|
EP2721004B1
(en)
|
2011-06-14 |
2017-07-26 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
|
WO2013003307A1
(en)
|
2011-06-28 |
2013-01-03 |
Wisconsin Alumni Research Foundation |
2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs
|
US20130178449A1
(en)
|
2011-07-18 |
2013-07-11 |
Wisconsin Alumni Research Foundation |
2-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D Analogs
|
US20130053356A1
(en)
|
2011-08-26 |
2013-02-28 |
Hector F. DeLuca |
2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3
|
EP2751075B1
(en)
|
2011-08-30 |
2018-01-17 |
Wisconsin Alumni Research Foundation |
Crystallization of 1 alpha-hydroxy-20-methylene-19,24,25,26,27-pentanorvitamin d3
|
US8420839B1
(en)
|
2011-10-05 |
2013-04-16 |
Wisconsin Alumni Research Foundation |
Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol
|
EP2768804B1
(en)
|
2011-10-21 |
2018-02-28 |
Wisconsin Alumni Research Foundation |
2-methylene-vitamin d analogs and their uses
|
US8729054B2
(en)
|
2011-10-21 |
2014-05-20 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-vitamin D analogs and their uses
|
US8455467B2
(en)
|
2011-10-21 |
2013-06-04 |
Wisconsin Alumni Research Foundation |
2-methylene-vitamin D analogs and their uses
|
US8940916B2
(en)
*
|
2012-05-30 |
2015-01-27 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US9040728B2
(en)
|
2012-05-30 |
2015-05-26 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) 19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US9212137B2
(en)
|
2012-05-30 |
2015-12-15 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 and related precursors
|
US8884039B2
(en)
|
2012-05-30 |
2014-11-11 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3
|
US8785422B2
(en)
|
2012-06-06 |
2014-07-22 |
Wisconsin Alumni Research Foundation |
A-ring modified 19-nor-vitamin D analogs and their uses
|
CA2877680C
(en)
|
2012-06-29 |
2017-08-29 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-(20s)-1.alpha., 25-dihydroxyvitamin d3 to treat secondary hyperparathyroidsm
|
EP2746252A1
(en)
|
2012-12-21 |
2014-06-25 |
Wisconsin Alumni Research Foundation (WARF) |
Crystallization of 1alpha-hydroxy-2-methylene- 18,19-dinor-homopregnacalciferol
|
US9416102B2
(en)
*
|
2013-01-23 |
2016-08-16 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
|
US10369161B2
(en)
|
2014-12-30 |
2019-08-06 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
|
US9539264B2
(en)
|
2014-12-30 |
2017-01-10 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
|
WO2016191583A1
(en)
|
2015-05-26 |
2016-12-01 |
Wisconsin Alumni Research Foundation |
1α,25-DIHYDROXY-24,24-DIFLUORO-19-NOR-VITAMIN D3 ANALOGS AND THEIR PHARMACEUTICAL USES
|
WO2017184262A1
(en)
|
2016-04-18 |
2017-10-26 |
Wisconsin Alumni Research Foundation |
Use of 2amd and 2md to treat fibrosis
|
US10105375B2
(en)
|
2016-08-30 |
2018-10-23 |
Wisconsin Alumni Research Foundation |
Combination of low dose 2-methylene-19-nor-(20S)1α, 25-dihydroxyvitamin D3 and calcimimetics to treat secondary hyperparathyroidism
|